PDL BIOPHARMA INC COM - COM (Y104L)

CUSIP: 69329Y104

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
95,629,140
Share change
+4,765,431
Total reported value
$278,485,332
Put/Call ratio
32%
Price per share
$2.91
Number of holders
126
Value change
+$13,919,108
Number of buys
53
Number of sells
55

Quarterly Holders Quick Answers

What is CUSIP 69329Y104?
CUSIP 69329Y104 identifies Y104L - PDL BIOPHARMA INC COM - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q2 2020

As of 30 Jun 2020, PDL BIOPHARMA INC COM - COM (Y104L) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,629,140 shares. The largest 10 holders included BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, VANGUARD GROUP INC, BRANDES INVESTMENT PARTNERS, LP, Silver Point Capital L.P., NORTHERN TRUST CORP, Connor, Clark & Lunn Investment Management Ltd., and Engine Capital Management, LP. This page lists 126 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.